Enliven Therapeutics Inc (ELVN)

Nov 19, 2024

Short Interest in Enliven Therapeutics, Inc. (NASDAQ:ELVN) Increases By 6.1% - MarketBeat

Nov 19, 2024

Nov 19, 2024

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Bought by First Turn Management LLC - MarketBeat

Nov 19, 2024

Nov 19, 2024

Robert W. Baird Issues Positive Forecast for Enliven Therapeutics (NASDAQ:ELVN) Stock Price - Defense World

Nov 19, 2024

Nov 16, 2024

Enliven Therapeutics has cash runway into late 2026 - BizWest

Nov 16, 2024

Nov 15, 2024

Robert W. Baird Forecasts Strong Price Appreciation for Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat

Nov 15, 2024

Nov 15, 2024

RA Capital Management, L.P. Reduces Stake in Enliven Therapeutics Inc. - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Citadel Advisors LLC Adjusts Stake in Enliven Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

COMMODORE CAPITAL LP Expands Stake in Enliven Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Enliven Therapeutics Reports Q3 Results and Clinical Progress - TipRanks

Nov 14, 2024

Nov 13, 2024

Polar Capital Holdings Plc's Strategic Acquisition in Enliven Th - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Enliven Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update - Yahoo Finance

Nov 13, 2024

Nov 11, 2024

(ELVN) Investment Analysis and Advice - Stock Traders Daily

Nov 11, 2024

Nov 07, 2024

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference - StockTitan

Nov 07, 2024

Nov 01, 2024

How to Take Advantage of moves in (ELVN) - Stock Traders Daily

Nov 01, 2024

Oct 31, 2024

Jones Trading Initiates Coverage of Enliven Therapeutics (ELVN) with Buy Recommendation - MSN

Oct 31, 2024

Oct 31, 2024

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Oct 31, 2024

Oct 31, 2024

Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 By Investing.com - Investing.com South Africa

Oct 31, 2024

Oct 30, 2024

Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 - Investing.com

Oct 30, 2024

Oct 27, 2024

Enliven Therapeutics (ELVN) Price Target Increased by 10.75% to 35.02 - MSN

Oct 27, 2024

Oct 23, 2024

Enliven Therapeutics CFO sells $24,422 in stock By Investing.com - Investing.com Australia

Oct 23, 2024

Oct 22, 2024

Enliven Therapeutics CFO sells $24,422 in stock - Investing.com

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics chief medical officer sells $24,482 in stock By Investing.com - Investing.com Canada

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics chief medical officer sells $24,482 in stock - Investing.com India

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics COO Anish Patel sells $21,482 in stock - Investing.com

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics COO Anish Patel sells $21,482 in stock By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics' chief scientific officer sells $25,412 in stock By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics CEO Kintz sells $27,722 in stock - Investing.com

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics' chief scientific officer sells $25,412 in stock - Investing.com India

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics director Heyman sells $47,104 in stock By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics CEO Kintz sells $27,722 in stock By Investing.com - Investing.com Australia

Oct 22, 2024

Oct 22, 2024

Enliven Therapeutics director Heyman sells $47,104 in stock - Investing.com India

Oct 22, 2024

Oct 22, 2024

Anish Patel Sells 716 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat

Oct 22, 2024

Oct 21, 2024

When (ELVN) Moves Investors should Listen - Stock Traders Daily

Oct 21, 2024

Oct 21, 2024

Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Oct 21, 2024

Oct 19, 2024

ELVN stock soars to 52-week high, reaching $28.66 By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 18, 2024

Enliven Therapeutics (NASDAQ:ELVN) Reaches New 52-Week HighHere's Why - MarketBeat

Oct 18, 2024

Oct 17, 2024

Richard A. Heyman Sells 1,270 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat

Oct 17, 2024

Oct 15, 2024

Enliven Therapeutics Inc [ELVN] Insider Lyssikatos Joseph P sells 37,878 Shares - Knox Daily

Oct 15, 2024

Oct 15, 2024

Enliven Therapeutics Inc (ELVN) stock analysis: A simple moving average approach - US Post News

Oct 15, 2024

Oct 15, 2024

Financial Metrics Check: Enliven Therapeutics Inc (ELVN)’s Ratios for Trailing Twelve Months - The Dwinnex

Oct 15, 2024

Oct 15, 2024

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Update - MarketBeat

Oct 15, 2024

Oct 14, 2024

Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why - Benzinga

Oct 14, 2024

Oct 10, 2024

Insider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Sells 10,420 Shares of Stock - MarketBeat

Oct 10, 2024

Oct 10, 2024

Enliven Therapeutics executive sells over $1.4 million in company stock - Investing.com India

Oct 10, 2024

Oct 10, 2024

Enliven Therapeutics director sells over $290k in company stock - Investing.com

Oct 10, 2024

Oct 10, 2024

Enliven Therapeutics director sells over $290k in company stock By Investing.com - Investing.com UK

Oct 10, 2024

Oct 10, 2024

Enliven Therapeutics (NASDAQ:ELVN) Trading Down 5.6%What's Next? - MarketBeat

Oct 10, 2024

Oct 10, 2024

Enliven Therapeutics CEO sells over $840k in company stock - Investing.com

Oct 10, 2024